Kidney Stones in Third Trimester: Frequency and Clinical Context
Most symptomatic kidney stones during pregnancy occur in the third trimester, representing approximately 55% of cases, with an overall incidence of symptomatic urolithiasis during pregnancy ranging from 0.35% to 1 in 200-1500 pregnancies 1, 2.
Epidemiology and Timing
The third trimester is the peak period for symptomatic kidney stone presentation during pregnancy. In a retrospective study of 18 pregnant women with urolithiasis, 55.5% of cases occurred during the third trimester 1. This timing pattern is clinically significant because:
- Stone laterality: Stones occur on both sides (right and left) with relatively equal frequency, and bilateral stones can occur 1
- Clinical presentation: Flank pain is the predominant symptom (94.4% of cases) 1
- Complications: Third trimester presentation carries risks of preterm labor, prolonged hospitalization, and increased maternal morbidity 3, 2
Clinical Significance and Outcomes
Pregnant women with renal calculi face substantially elevated complication rates—84.7% experience labor and delivery complications compared to 28.8% without stones, and hospital stays are twice as long (5.12 vs 2.56 days) 3. This represents a critical maternal health concern requiring heightened surveillance.
Key Risk Factors
- Multiparous women are more commonly affected 4
- Lower socioeconomic status and Medicaid/Medicare insurance are associated with higher complication rates 3
- Mean age at presentation is approximately 27 years 4
Diagnostic Approach
Ultrasound should be the first-line imaging modality with 95.2% sensitivity for detecting renal calculi in pregnancy 5, 4. The diagnostic algorithm proceeds as follows:
- Initial evaluation: Transabdominal ultrasound (noninvasive, no radiation)
- If uncertainty persists: Transvaginal ultrasound for distal ureteral stones (94% detection rate) 5
- Advanced imaging when needed: Non-contrast MRI (80% positive predictive value) or low-dose CT if maternal benefit outweighs fetal risk 5
Important caveat: Physiologic hydronephrosis of pregnancy can confound ultrasound interpretation, and microscopic urinalysis is not helpful for identifying stone disease in pregnant patients 4.
Management Considerations
Conservative management with observation succeeds in 64.3% of cases, with spontaneous stone passage occurring in 40-60% of women over 17-35 days 5, 4. However, intervention becomes necessary when:
- Persistent pain despite conservative measures
- Signs of infection (pyelonephritis risk is approximately 2%)
- Obstructive uropathy
When intervention is required, ureteroscopy (URS) is safe during pregnancy with no difference in endoscopic complications compared to non-pregnant patients, though there is a 4.3% risk of obstetric complications including preterm labor 5. The preferred timing for surgical intervention is the second trimester after fetal viability is reached 5.
Treatment Algorithm for Third Trimester Stones:
- Well-controlled symptoms: Trial of conservative management with hydration and analgesia
- Persistent pain: Double-J stent placement (successful in most cases) 1, 4
- Failed stent placement or intractable symptoms: Ureteroscopic lithotripsy under epidural anesthesia 1
- Pyonephrosis or severe obstruction: Percutaneous nephrostomy 1
Critical Pitfalls
- Misdiagnosis or inadequate treatment can lead to pyelonephritis and premature labor, with potential fetal loss 4
- Long-term antibiotic prophylaxis is essential for all stented and bacteriuric patients 4
- Coordination with obstetrics is mandatory for any imaging involving ionizing radiation or surgical intervention 5
The third trimester concentration of symptomatic stones likely reflects cumulative physiologic changes including urinary stasis, increased calcium excretion, and progressive ureteral dilation that characterize pregnancy.